Abstract:The inflammatory response is a defense mechanism of the innate immune system against infections and other injuries. In response to microbial components, macrophages activate primary and secondary inflammatory gene programs crucial for host defense. De la Rosa et al. provide evidence that inflammation triggers a reprogramming of the transcription factor liver X receptor α (LXRα), that sustains cytokine and chemokine gene expression through direct binding to DNA consensus sequences and collaboration with NF‐κB at enhancers of secondary inflammatory response genes. This novel TLR4‐LXRα‐NF‐κB axis supports macrophage inflammatory gene expression and in vivo immune‐cell recruitment during inflammatory responses to microbial ligands, positioning LXRα as a key factor in the transcriptional regulation in the late stages of inflammation. Macrophages regulate essential aspects of innate immunity against pathogens. In response to microbial components, macrophages activate primary and secondary inflammatory gene programs crucial for host defense. The liver X receptors (LXRα, LXRβ) are ligand‐dependent nuclear receptors that direct gene expression important for cholesterol metabolism and inflammation, but little is known about the individual roles of LXRα and LXRβ in antimicrobial responses. Here, the author demonstrate that induction of LXRα transcription by prolonged exposure to lipopolysaccharide (LPS) supports inflammatory gene expression in macrophages. LXRα transcription is induced by NF‐κB and type‐I interferon downstream of TLR4 activation. Moreover, LPS triggers a reprogramming of the LXRα cistrome that promotes cytokine and chemokine gene expression through direct LXRα binding to DNA consensus sequences within cis‐regulatory regions including enhancers. LXRα‐deficient macrophages present fewer binding of p65 NF‐κB and reduced histone H3K27 acetylation at enhancers of secondary inflammatory response genes. Mice lacking LXRα in the hematopoietic compartment show impaired responses to bacterial endotoxin in peritonitis models, exhibiting reduced neutrophil infiltration and decreased expansion and inflammatory activation of recruited F4/80lo‐MHC‐IIhi peritoneal macrophages. Together, these results uncover a previously unrecognized function for LXRα‐dependent transcriptional cis‐activation of secondary inflammatory gene expression in macrophages and the host response to microbial ligands.

Liver X receptors link lipid metabolism and inflammation

Liver X Receptors: Regulators of Cholesterol Metabolism, Inflammation, Autoimmunity, and Cancer

Liver X Receptors Regulate Cholesterol Metabolism and Immunity in Hepatic Nonparenchymal Cells

LXR directly regulates glycosphingolipid synthesis and affects human CD4+ T cell function

Liver X receptors as potential therapeutic targets for multiple diseases.

Untangling the inflammatory responses of liver x receptor (LXR) activation in human macrophages

Liver X receptors conserve the therapeutic target potential for the treatment of rheumatoid arthritis

Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases

LXR Suppresses Inflammatory Gene Expression and Neutrophil Migration through cis-Repression and Cholesterol Efflux.

Reprogramming of the LXRα Transcriptome Sustains Macrophage Secondary Inflammatory Responses

Crosstalk Between Liver Macrophages and Gut Microbiota: an Important Component of Inflammation-Associated Liver Diseases

LXR Activation Induces a Proinflammatory Trained Innate Immunity-Phenotype in Human Monocytes

Regulatory mechanism underlying liver X receptor effects on the tumor microenvironment, inflammation and tumorigenesis

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

Activation of liver X receptor suppresses the production of the IL-12 family of cytokines by blocking nuclear translocation of NF-κBp50

Liver X Receptors (LXRs) in cancer-an Eagle's view on molecular insights and therapeutic opportunities

Liver X receptor: a potential target in the treatment of atherosclerosis

Activation of liver X receptor attenuates lysophosphatidylcholine-induced IL-8 expression in endothelial cells via the NF-κB pathway and SUMOylation

Molecular mechanism of liver X receptors in cancer therapeutics

Regulation Of Insulin Resistance And Adiponectin Signaling In Adipose Tissue By Liver X Receptor Activation Highlights A Cross-Talk With Ppar Gamma

Liver X Receptors (lxrs) Regulate Apolipoprotein Aiv-Implications of the Antiatherosclerotic Effect of Lxr Agonists